157 related articles for article (PubMed ID: 18544603)
1. Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
Lamaris GA; Ben-Ami R; Lewis RE; Kontoyiannis DP
J Antimicrob Chemother; 2008 Sep; 62(3):539-42. PubMed ID: 18544603
[TBL] [Abstract][Full Text] [Related]
2. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
[TBL] [Abstract][Full Text] [Related]
3. Interstrain variability in the virulence of Aspergillus fumigatus and Aspergillus terreus in a Toll-deficient Drosophila fly model of invasive aspergillosis.
Ben-Ami R; Lamaris GA; Lewis RE; Kontoyiannis DP
Med Mycol; 2010 Mar; 48(2):310-7. PubMed ID: 19642052
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
Krishnan S; Manavathu EK; Chandrasekar PH
J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
[TBL] [Abstract][Full Text] [Related]
5. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.
Lionakis MS; Lewis RE; May GS; Wiederhold NP; Albert ND; Halder G; Kontoyiannis DP
J Infect Dis; 2005 Apr; 191(7):1188-95. PubMed ID: 15747256
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
[TBL] [Abstract][Full Text] [Related]
7. Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
Heinz WJ; Egerer G; Lellek H; Boehme A; Greiner J
Mycoses; 2013 May; 56(3):304-10. PubMed ID: 23170837
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Stiefel M; Reiss T; Staege MS; Rengelshausen J; Burhenne J; Wawer A; Foell JL
Pediatr Blood Cancer; 2007 Aug; 49(2):203-7. PubMed ID: 16333861
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus.
Tell LA; Clemons KV; Kline Y; Woods L; Kass PH; Martinez M; Stevens DA
Med Mycol; 2010 Mar; 48(2):234-44. PubMed ID: 19548171
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
Forastiero A; Bernal-Martínez L; Mellado E; Cendejas E; Gomez-Lopez A
Int J Antimicrob Agents; 2015 Nov; 46(5):511-7. PubMed ID: 26358971
[TBL] [Abstract][Full Text] [Related]
12. Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
Chryssanthou E; Loebig A; Sjölin J
J Antimicrob Chemother; 2008 Jun; 61(6):1309-11. PubMed ID: 18367461
[TBL] [Abstract][Full Text] [Related]
13. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
[TBL] [Abstract][Full Text] [Related]
14. Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
Lamaris GA; Chamilos G; Lewis RE; Kontoyiannis DP
J Infect Dis; 2007 Dec; 196(12):1860-4. PubMed ID: 18190268
[TBL] [Abstract][Full Text] [Related]
15.
Kimura G; Nakaoki T; Colley T; Rapeport G; Strong P; Ito K; Kizawa Y
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630185
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
Paulussen C; Boulet G; Bosschaerts T; Cos P; Fortin A; Maes L
Mycoses; 2015 Mar; 58(3):127-32. PubMed ID: 25590577
[TBL] [Abstract][Full Text] [Related]
17. Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
Colley T; Sehra G; Daly L; Kimura G; Nakaoki T; Nishimoto Y; Kizawa Y; Strong P; Rapeport G; Ito K
Sci Rep; 2019 Jul; 9(1):9482. PubMed ID: 31263150
[TBL] [Abstract][Full Text] [Related]
18. Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.
Mavridou E; Bruggemann RJ; Melchers WJ; Verweij PE; Mouton JW
Antimicrob Agents Chemother; 2010 Nov; 54(11):4758-64. PubMed ID: 20733046
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
Liu W; Lionakis MS; Lewis RE; Wiederhold N; May GS; Kontoyiannis DP
Antimicrob Agents Chemother; 2003 Nov; 47(11):3592-7. PubMed ID: 14576123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
